ON-DEMAND 
Compliance with data integrity and computerised system validations
ON-DEMAND By PerkinElmer
During this webinar, we investigated trends seen globally for data integrity violations and avenues for remediation.
List view / Grid view
Webinars
ON-DEMAND 
Harmonising drug-target binding data analytics on a single platform
ON-DEMAND By PerkinElmer
This webinar outlined the fundamentals of a design process where an experimental analytics data workflow is being integrated into a more seamlessly interactive platform...
ON-DEMAND 
Cell-based and biochemical high-throughput screening in 1536-well plates
ON-DEMAND By BMG Labtech GmbH
In this webinar, we presented two examples of HTS in 1536-well plates, a screen for protein-protein interactions and a cell-based luciferase reporter assay.
ON-DEMAND 
Integrated fragment-based approach reveals enzymatic inhibitors with potential therapeutic application
ON-DEMAND By NanoTemper Technologies
In this webinar, speakers presented results of integrated fragment-based approaches that have led to the discovery of the first ligands of IDO1 that are able to modulate non-catalytic signalling functions of the enzyme...
ON-DEMAND 
Recent advances in diagnostics and treatments – from small molecules to cellular therapies
ON-DEMAND By Bio-Techne
With recent advances in medicine, cellular therapies are one step closer to becoming a reality where re-programmed cells, tissues and organs can be used as therapeutic agents. This webinar discussed the journey of medical treatments from small molecule to cellular therapies...
ON-DEMAND 
Using bioactivity profiling to support the progression of phenotypic hits
ON-DEMAND By Eurofins Pharma Discovery Services
In this webinar, we discussed a recent case study where a phenotypic screen was performed using poly I:C / IL-4 stimulated human bronchial epithelial cells. This resulted in the identification of 7 representative hits which provided starting points for new drug discovery opportunities.
ON-DEMAND 
High throughput screening for deep mining of antibody repertoires, Dr. Stefan Moese, Novartis, Switzerland
ON-DEMAND By Beckman Coulter
In this webinar you learn about a high throughput screening approach for mining of antibody repertoires in the context of biologics drug discovery.
ON-DEMAND 
Streamlining drug discovery assays for cancer and cardiovascular disease
ON-DEMAND By PerkinElmer
This webinar discussed a screening assay that recapitulates the activation of ER stress sensor IRE1 and an assay to quantify cell migration phenotypes, as applied to cardiovascular target validation and drug discovery.
ON-DEMAND 
High throughput flow cytometry for multifactorial evaluation of novel therapeutic candidates using an innovative In vitro immuno-oncology screening platform
ON-DEMAND By IntelliCyt Corporation
In this webinar, speakers discussed how the IntelliCyt iQue Screener Plus platform is being utilised to deliver rich datasets for compound screening, target validation and is how it is transforming immuno-oncology.
ON-DEMAND 
High performance computing for high content screening – A case study
ON-DEMAND By PerkinElmer
In this webinar, PerkinElmer and AMRI will present a case study wherein high-performance computing (HPC) was leveraged for enhanced performance in image and data analysis of High Content Screening experiments...
ON-DEMAND 
Use of IntelliCyt’s iQue Screener for high-throughput screening of small molecules, CRISPRs and stem cells
ON-DEMAND By Intellicyt
This webinar highlights the use of the iQue Screener for high-throughput screening of stem cells, small molecules and CRISPR functional screening, presented by David Sykes, M.D., Ph.D., Researcher from Massachusetts General Hospital and Thibault Jonckheere, CEO and Séverine Giltaire, Senior Scientist from ImmunXperts...
ON-DEMAND 
Evaluating immunotherapeutic approaches with large scale functional assays for immuno-oncology
ON-DEMAND By IntelliCyt Corporation
In this webinar, Belen Ybarrondo, Ph.D and Thomas Duensing, Ph.D discuss the need for robust high content tools for current immunotherapeutic approaches, and how IntelliCyt's iQue Screener PLUS can give functional efficacy of immuno-oncology therapies...
ON-DEMAND 
Advancing the discovery of immunotherapeutics with large scale multiplexed experiments
ON-DEMAND By IntelliCyt Corporation
In this webinar, Belen Ybarrondo, Ph.D and Thomas Duensing, Ph.D discuss the challenges faced with antibody screening and how the iQue Screener can give an evaluation of cell killing mechanism, screening for immune checkpoint inhibitors and more...
ON-DEMAND 
Identification of antibodies against difficult targets
ON-DEMAND By IntelliCyt
Identification of antibodies against challenging targets using high throughput multiplex-screening approaches...
ON-DEMAND 
Immunology Screening on the iQue Screener
ON-DEMAND By IntelliCyt
Immunology Screening on the iQue Screener: Assays for Immune-Modulators and Immunotherapy...
Follow: